NCT03398083View on ClinicalTrials.gov

Evaluation of the Effects of Cannabidiol (CBD) Compared to Delta-9-Tetrahydrocannabinol (THC) and Alprazolam

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 4, 2017

Primary Completion Date

May 30, 2018

Study Completion Date

May 30, 2018

Conditions

Cannabis Use Disorder

Interventions

DRUG

THC

THC capsule

DRUG

Alprazolam

Alpraxolam capsule

DRUG

Placebo oral capsule

Sugar pill capsule

DRUG

CBD

CBD capsule

Trial Locations (1)

66212

Debra Kelsh, MD, Overland Park

All Listed Sponsors

lead

National Institute on Drug Abuse (NIDA)

NIH

NCT03398083 - Evaluation of the Effects of Cannabidiol (CBD) Compared to Delta-9-Tetrahydrocannabinol (THC) and Alprazolam | Biotech Hunter | Biotech Hunter